Food Sensitivities and Weight Plateau

A patient told me last week that she had eliminated gluten, dairy, soy, eggs, corn, and nightshades, lost six pounds in the first two weeks, and then watched the scale freeze for four months. She felt no better, was eating chicken and rice for nearly every meal, and was convinced she had to find the next food that was sabotaging her. She had not had labs drawn in two years. Her last documented fasting insulin was 21. Her TSH was 3.4 with no free T3. She was 46.

I see this pattern constantly. Smart, motivated patients who have read everything, eliminated everything, and stalled out — because the underlying problem was never the food. It was the metabolic and hormonal context the food was being processed in. Food sensitivities can be real and worth identifying. They are also, in my experience, dramatically over-blamed for weight plateaus that have nothing to do with sensitivities and everything to do with insulin, thyroid, sex hormones, and sleep.

This article is the conversation I have with patients who walk in convinced the next elimination diet will be the answer. Sometimes it would be. More often, the answer is somewhere else entirely.

Where food sensitivities actually fit — and where they do not

Let me be precise about what we are talking about. There are three distinct things people lump under "food sensitivity":

1. True IgE-mediated food allergy. Anaphylaxis, hives, airway involvement. Diagnosed with skin testing or specific IgE. Real, dangerous, and not what we are discussing here.
2. Celiac disease and confirmed enteropathies. Diagnosed with serology (tTG-IgA, total IgA) and biopsy. Real, well-defined, and treated with strict elimination of the offending protein. Worth screening for in patients with GI symptoms, iron-deficiency anemia of unclear cause, infertility, or family history.
3. Non-celiac food sensitivities. Symptom-driven, often diagnosed by elimination and reintroduction, sometimes by IgG panels (which I am skeptical of — the evidence is weak). Can be real for individual patients. Frequently over-diagnosed.

Where the third category genuinely affects weight is when the food in question is driving systemic inflammation, gut symptoms severe enough to disrupt absorption, or behavioral eating patterns (a food that triggers cravings or a binge cycle). Where it does not affect weight in the way patients hope is when the patient already eats a clean diet, the food has been eliminated for months, and the scale still will not move. At that point, the food is not the problem.

The actual mechanisms behind a mid-life weight plateau

When I work up a weight plateau in a patient over 40, the differential I run through has very little to do with food sensitivities. It looks like this:

• Insulin resistance. This is the single most common driver. Fasting insulin above 10 mIU/L in the context of normal fasting glucose tells me the pancreas is compensating to keep glucose in range. Elevated insulin is a fat-storage signal that overrides caloric deficit. You can be in a 500-calorie deficit and not lose fat if your insulin is high enough — your body will pull from lean tissue and water before it gives up adipose. HOMA-IR over 1.9 is a meaningful finding. I want optimal under 1.5.
• Thyroid drag. Subclinical hypothyroidism — TSH between 2.5 and 5 with low-normal free T3 — slows basal metabolic rate by 5 to 15 percent. That is the difference between losing weight and not losing weight at the same intake. Reverse T3 elevation, common under chronic stress or chronic dieting, blocks T3 from binding to its receptor. The patient is "euthyroid" on paper and hypothyroid in tissue.
• Sex hormone decline. In women, declining estradiol shifts fat distribution toward the midsection and reduces insulin sensitivity. Low progesterone disrupts sleep, which compounds the metabolic problem. Low free testosterone reduces lean mass, which lowers metabolic rate. In men, low testosterone does the same — visceral adiposity, reduced muscle mass, worsened insulin signaling, fatigue that suppresses training.
• Cortisol pattern disruption. Elevated evening cortisol or a flattened diurnal curve directly promotes visceral fat storage and antagonizes thyroid hormone conversion. Chronic dieters with chronic stress run this pattern almost universally.
• Sleep architecture. Six hours of fragmented sleep produces measurable insulin resistance the next day. A patient who has been undersleeping for years has been operating in a state that mimics insulin resistance even if their underlying metabolism would otherwise be fine.
• Sarcopenia. Loss of lean muscle mass over years of being sedentary or under-trained is a quiet driver of metabolic slowdown. Resistance training is non-negotiable in any serious weight loss plan.

Notice what is not in that list: gluten. Dairy. Nightshades. They are not in the list because they are rarely the actual driver in the patient who is over 40, eats reasonably well, and cannot lose weight.

How I evaluate a true plateau

The first visit in the medical weight loss program is structured. I want a detailed history of every weight loss attempt — what was tried, how long, what worked, what stalled, what was regained. I want a current 7-day food log written honestly, not aspirationally. I want training history, sleep pattern, medications, supplements, and stress baseline.

Then I run labs. The panel for a weight plateau evaluation:

• Metabolic: fasting insulin, fasting glucose, HbA1c, comprehensive metabolic panel, lipid panel with triglyceride-to-HDL ratio, hs-CRP
• Thyroid: TSH, free T3, free T4, reverse T3, TPO and thyroglobulin antibodies
• Sex hormones: estradiol, progesterone, total and free testosterone, DHEA-S, SHBG; in men, also LH and FSH
• Cortisol: morning serum cortisol; sometimes a four-point salivary panel if the symptom story warrants it
• Add-ons: ferritin, vitamin D, B12, magnesium; celiac screen (tTG-IgA, total IgA) when GI symptoms or family history suggest it; leptin in selected cases

The patient gets a copy of every result. We meet again in one to two weeks for the lab review.

What I look for on the review

I am looking for the pattern that explains why the plateau is happening. In the patient I described at the top of this article — the one eliminating six food groups — the labs showed a fasting insulin of 19, an HbA1c of 5.8, a TSH of 3.4 with a free T3 in the bottom quartile, an estradiol consistent with late perimenopause, and a vitamin D of 24. Her plateau had nothing to do with corn or nightshades. It had everything to do with insulin resistance, thyroid drag, hormonal transition, and a deficiency we needed to repair.

When the labs do show a relevant food issue — celiac serology positive, or a genuine clinical pattern that points to a specific intolerance — we address it directly and refer for confirmatory workup when needed. That happens in maybe one out of fifteen plateau evaluations. The other fourteen need a different intervention.

How treatment proceeds — the 90-day structured phase

The first 30 days establish the diagnostic picture and start the highest-leverage intervention. If insulin resistance is the dominant driver, that often means initiating GLP-1 therapy at a conservative dose. GLP-1 receptor agonists work because they directly address the mechanism — they slow gastric emptying, suppress appetite at the brain level, and improve insulin sensitivity. Semaglutide produces roughly 15 percent body weight loss over 68 weeks; tirzepatide produces roughly 21 percent. These are the most effective pharmacological tools we have for the metabolic phenotype that drives most mid-life plateaus.

Concurrently, I address what is layered on top: thyroid optimization if the panel supports it, hormone optimization if the sex hormone picture is part of the story, vitamin D and other deficiencies repaired, and a real conversation about resistance training. Building or preserving muscle is non-negotiable on GLP-1 — sarcopenia is the failure mode of poorly-managed GLP-1 use. We work with nutritional counseling on protein intake (1.2 to 1.6 g/kg of goal body weight), and I coordinate on training when appropriate.

The next 30 days are about titration. GLP-1 dose moves up based on tolerance. Side effects (nausea, reflux, constipation) are managed with specific protocols — not endured. We re-check body composition where DEXA is appropriate to confirm we are losing fat, not muscle.

The final 30 days are optimization and the maintenance plan. Labs are re-run. The plan beyond day 90 is built deliberately. The most common failure pattern I see in medical weight loss is patients who lose weight, stop the framework, and regain. I refuse to let that be the default ending.

What I tell patients who are sure it is a food sensitivity

I do not dismiss them. Sometimes they are right. But before we do another elimination diet, we run the labs. If the labs show insulin resistance, thyroid drag, or hormonal decline as the dominant driver, the elimination diet is going to disappoint them again — and they have already been disappointed enough. If the labs are clean and the symptom story really does point to a food trigger, a structured elimination and reintroduction with nutritional counseling is reasonable. But I will not let a patient spend another six months chasing a food explanation when the data points somewhere else.

The concrete next step

If you have plateaued, if you have been eliminating foods without results, or if your weight has not responded to anything in the last six months — get the metabolic and hormonal panel run before you remove another food group. Take the weight loss assessment to focus the first visit, then book at the Columbus clinic or Warner Robins clinic. Bring any labs from the past 12 months, your current food log, and a list of what you have already tried. The first visit gathers the data; the second visit interprets it; the 90-day plan is built from your actual physiology, not from the average patient or the latest elimination protocol on the internet.

TW

Travis Woodley

MSN, RN, CRNP — Platinum Biote Provider — Founder, Revitalize

Travis spent 17+ years in high-acuity clinical medicine — emergency, cardiac ICU, and cath lab — before founding Revitalize. He is a Certified Platinum Biote hormone therapy provider, the published author of You're Not Broken — You're Unbalanced, and the founder of the Rebuild Metabolic Health Institute. His clinical writing reflects the same precision he brought to critical care: specific, honest, and built around what actually works.

Book a ConsultationCall (762) 261-3880

About Travis →More articles →Rebuild Institute →